Partnership Between Parexel and Palantir to Enhance Clinical Trials
April 30, 2024
Parexel, a leading clinical research organization, has partnered with Palantir Technologies with the intent of using AI to improve clinical trials for biopharmaceutical clients. Parexel will integrate Palantir’s Foundry and AI Platform into its clinical data system to enhance trial efficiency while maintaining safety and regulatory standards. This move expands their previous collaboration and marks Parexel as the first CRO to use Palantir’s AI tools in this capacity. Jonathan Shough, Parexel’s CIO, emphasized the benefits of AI to optimize clinical trial execution and develop new solutions in Real World Evidence and advanced analytics. Palantir’s technology will help automate processes, improve data accessibility, and shorten timelines from trial planning to submission, ensuring high-quality, transparent data for clients.
To read more, click here.
[Source: PharmBiz, April 29, 2024]
